Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Latrunculin B

😃Good
Catalog No. T20636Cas No. 76343-94-7
Alias NSC-339663, NSC339663, NSC 339663, LAT-B, LATB, LAT B, INS115644

Latrunculin B, an alkaloid from the Red Sea sponge, is an actin polymerization inhibitor with antifungal and antiprotozoal activity.Latrunculin B modulates the electrophysiological characteristics of the pulmonary veins and attenuates the occurrence of torsade de pointes, and may be used in the study of glaucoma in adolescents.

Latrunculin B

Latrunculin B

😃Good
Catalog No. T20636Alias NSC-339663, NSC339663, NSC 339663, LAT-B, LATB, LAT B, INS115644Cas No. 76343-94-7
Latrunculin B, an alkaloid from the Red Sea sponge, is an actin polymerization inhibitor with antifungal and antiprotozoal activity.Latrunculin B modulates the electrophysiological characteristics of the pulmonary veins and attenuates the occurrence of torsade de pointes, and may be used in the study of glaucoma in adolescents.
Pack SizePriceAvailabilityQuantity
1 mg948 €35 days
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Latrunculin B, an alkaloid from the Red Sea sponge, is an actin polymerization inhibitor with antifungal and antiprotozoal activity.Latrunculin B modulates the electrophysiological characteristics of the pulmonary veins and attenuates the occurrence of torsade de pointes, and may be used in the study of glaucoma in adolescents.
Targets&IC50
HeLa cells:1.4 μM
In vitro
Displaying growth inhibition of HeLa cells with an IC50 value of 1.4 μM, Latrunculin B also modulates electrophysiological characteristics and arrhythmogenesis in pulmonary vein cardiomyocytes[1].
In pulmonary vein (PV) preparations, Latrunculin B (100 nM) decreases spontaneous electrical activity by 16±4%. Moreover, it reduces the late Na+ current, L-type Ca2+ current, Na+/Ca2+ exchanger current, and stretch-activated BKCa current in PV cardiomyocytes. Latrunculin B alters the transient outward K+ current and ultra-rapid delayed rectifier K+ current, while increasing the delayed rectifier K+ current in isolated PV cardiomyocytes. Additionally, at a concentration of 100 nM, Latrunculin B decreases intracellular Ca2+ transient and sarcoplasmic reticulum Ca2+ content in PV cardiomyocytes, attenuating stretch-induced increased spontaneous electrical activity and trigger activity[2].
AliasNSC-339663, NSC339663, NSC 339663, LAT-B, LATB, LAT B, INS115644
Chemical Properties
Molecular Weight395.51
FormulaC20H29NO5S
Cas No.76343-94-7
SmilesC[C@H]1CC[C@@H]2C[C@H](C[C@@](O)(O2)[C@@H]2CSC(=O)N2)OC(=O)\C=C(C)/CC\C=C/1
Relative Density.no data available
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: Soluble

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Latrunculin B | purchase Latrunculin B | Latrunculin B cost | order Latrunculin B | Latrunculin B chemical structure | Latrunculin B in vitro | Latrunculin B formula | Latrunculin B molecular weight